These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7196561)

  • 1. Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
    Creagan ET; Eagan RT; Kvols LK
    Oncology; 1981; 38(5):260-1. PubMed ID: 7196561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
    [No Abstract]   [Full Text] [Related]  

  • 3. Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
    Vogl SE; Seltzer V; Camacho F; Calanog A
    Cancer Treat Rep; 1982 Oct; 66(10):1809-12. PubMed ID: 6889913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
    Goldhirsch A; Joss RA; Cavalli F; Sonntag RW; Brunner KW
    Med Pediatr Oncol; 1981; 9(3):205-8. PubMed ID: 6264280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
    Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
    Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
    Hahn RG; Bauer M; Wolter J; Creech R; Bennett JM; Wampler G
    Cancer Treat Rep; 1979 Mar; 63(3):513-5. PubMed ID: 371804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
    Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD; Scott M
    Cancer Treat Rep; 1982 Aug; 66(8):1647-9. PubMed ID: 7105055
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD; Baker L; Thigpen T
    Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination cis-platinum and etoposide in small-cell lung cancer.
    Natale RB; Wittes RE
    Cancer Treat Rev; 1982 Jun; 9 Suppl():91-4. PubMed ID: 6290058
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.
    Perry MC; Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Treat Rep; 1976 Sep; 60(9):1247-50. PubMed ID: 797447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinum.
    Mitrou PS; Fischer M; Weissenfels I; Diehl V; Gropp C; Liesenfeld A; Schmidt M; Berdel WE; Fink U; Graubner M
    Cancer Treat Rev; 1982 Jun; 9 Suppl():139-42. PubMed ID: 6889919
    [No Abstract]   [Full Text] [Related]  

  • 13. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R; Brugarolas A; Hansen H; Cavalli F; Ryssel H; Siegenthaler P; Clarysse A; Renard J; Kenis Y; Alberto P
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract]   [Full Text] [Related]  

  • 14. Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.
    Klastersky J; Longeval E; Nicaise C; Weerts D
    Cancer Treat Rev; 1982 Jun; 9 Suppl():133-8. PubMed ID: 6889918
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases.
    Creagan ET; Eagan RT; Rubin J
    Med Pediatr Oncol; 1979; 7(2):179-80. PubMed ID: 502975
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.
    Eagan RT; Creagan ET; Bisel HF; Layton DD; Groover RV; Herman RC
    Oncology; 1981; 38(1):4-6. PubMed ID: 7443176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitol.
    Eagan RT; Ames MM; Powis G; Kovach JS
    Cancer Treat Rep; 1982 Feb; 66(2):283-7. PubMed ID: 7034934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma.
    Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; O'Connell MJ; Frytak S
    Cancer Treat Rep; 1976 Nov; 60(11):1681-2. PubMed ID: 1021239
    [No Abstract]   [Full Text] [Related]  

  • 19. VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.
    Eagan RT; Creagan ET; Ingle JN; Rubin J; Frytak S; Kvols LK; Fleming TR
    Tumori; 1979 Feb; 65(1):105-9. PubMed ID: 442215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213].
    Joss R; Goldhirsch A; Cavalli F; Weber W; Kaplan S; Obrecht JP; Sonntag R; Brunner KW
    Schweiz Med Wochenschr; 1981 Sep; 111(36):1331-4. PubMed ID: 7197802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.